Through the first nine months of 2025, the company generated $422 million in revenue -- representing an increase of 39% year ...

Shares of Abbott Laboratories plunged 10.04% to $108.61 Thursday, on what proved to be an all-around great trading session ...

Rocket Lab (RKLB)’s stock surged 45%, driven not only by a robust 10% increase in revenue but also by a significant 36% ...

Rocket Lab shares are up on Friday as the company recently completed its first launch of 2026, marking its 80th Electron ...

Abbott Labs stock drops on sales miss and weak guidance for 2026, analyst cuts price target but maintains rating.

Rocket Lab looks overvalued despite Neutron/defense catalysts. Click here for more on the RKLB stock prospects.

Rocket Lab stock has continued to skyrocket in 2026 and is currently up 38% year to date. Meanwhile, the S&P 500 is up 1.4%, ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

As of Friday, January 09, Rocket Lab Corporation’s RKLB share price has surged by 5.63%, which has investors questioning if ...

Rocket Lab’s stock price already reflects the impact of major recent milestones and renewed enthusiasm for the space sector, ...

Rocket Lab (RKLB) surged 188% in 2025, but profits lag its $44B valuation. Neutron rocket’s success is pivotal. See here for a more detailed analysis.

Rocket Lab (NASDAQ: RKLB) closed out 2025's trading with another month of huge gains. The company's share price surged 65.5% ...